Ealixir
EAXR · OTC
About EAXR
- Employees
- 0
- Headquarters
- Miami, Florida
- Listed
- Jun 29, 1995
- Sector
- Information Technology
- Industry
- IT Services
- Website
- ealixir.com
EAXR key statistics
- Market cap
- 24.05M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 362
- Volume
- 10.10K
- Open price
- $0.40
- High today
- $0.55
- Low today
- $0.40
- 52 Week high
- $2.21
- 52 Week low
- $0.2121
Ealixir (EAXR) at a glance
As of Oct 20, 2026, Ealixir (EAXR) shares are priced at $0.55, giving the company a market cap of 24.05M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.40 and $0.55. The current price is 37.5% above the day's low and 0.0% below its high.
Volume so far is 10.10K shares, above the average of 362 shares a day.
Over the past year Ealixir has ranged from $0.2121 to $2.21, and now sits 17% of the way up that range.
Similar companies
Companies in the same industry as Ealixir
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.